Synonyms: GSK-2636771
Compound class:
Synthetic organic
Comment: GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, with anticancer effects in PTEN null cells [2].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid |
Synonyms ![]() |
GSK-2636771 |
Database Links ![]() |
|
CAS Registry No. | 1372540-25-4 |
ChEMBL Ligand | CHEMBL3188551 |
GtoPdb PubChem SID | 249565650 |
PubChem CID | 56949517 |
Search Google for chemical match using the InChIKey | XTKLTGBKIDQGQL-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | XTKLTGBKIDQGQL |
UniChem Compound Search for chemical match using the InChIKey | XTKLTGBKIDQGQL-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XTKLTGBKIDQGQL-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
GSK2636771 (links to external site)
Cat. No. HY-15245 |